Effects of meloxicam on implantation and parturition of rat

Jordan Medical Journal

Volumn 40, Issue 2, 2006, Pages

  Jaffal, Sahar M ^a   Salhab, Abdulazim S ^a   Disi, Ahmad M ^a   Al Qaadan, Farouq ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b HASHEMITE UNIVERSITY   (Jordan)

Author keywords

Anti implantation; Meloxicam; Oxytocin; Parturition; Resorption

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM; PLACEBO;

ANIMAL EXPERIMENT; ARTICLE; BLASTOCYTE; CHILDBIRTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FETAL WELL BEING; IMPLANTATION; MALE; NONHUMAN; PREGNANCY; RAT; REPRODUCTION; UTERUS;

EID: 33749468859     PISSN: 04469283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Feldman M, McMahon AT. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteriodal anti-inflammatory drugs with less gastrointestinal toxicity? Ann Intern Med 2000; 132: 134-143.
2. Li CFI, Wong CYG, Chan CPB, Ho PC. A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of first trimester pregnancy. Contraception 2003; 67: 101-105.
3. Quellet M, Riendeau D, Percival MD. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. PNAS 2001; 98: 14583-14588.
4. Selzer, Torsten. Dermal therapeutic system containing non-steroidal antiphlogistics with selective COX-2 inhibition. 2002; Patent no. DE 2000-10032132 20000701.
5. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB 1998; 12: 1063-1073.
6. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases-1 and -2. Ann Rev Pharmacol Toxicol 1998; 38: 97-120.
7. Gierse JK, McDonald JJ, Hauser SD, Rangwata SH, Koboldt CM, Seibert K. A single amino acid difference between cyclooxygenase -1 (COX-1) and (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem 1996; 271: 15810-15814.
8. Knijff-Dutmer EA, Kalsbeek-Batenburg EM, Koerts J, Van de laar MA. Platelet function is inhibited by nonselective nonsteriodal anti-inflammatory drugs but not by cyclooxygenase-2- selective inhibitors in patients with rheumatoid arthritis. Rheumatology 2002; 41: 458-461.
9. Capriotti T. The new NSAIDS: COX-2 inhibitors. Medsurg Nursing. 2000; 9: 313-317.
10. Turini ME, Dubois RN. Cyclooxygenase- 2: A Therapeutic Target. Ann Rev Med 2002; 53: 35-57.
11. Matsumoto H, Ma W, Smallery W, Trazaskos J, Breyer RM, Dey SK. Diversification of cyclooxygenase-2 derived prostaglandin in ovulation and implantation. Biol Reprod 2001; 64: 1557-1565.
12. Lim H, Paria BC, Das SK, Dinchuk JE, Lagenbachi R, Trzaskos JM Dey Sk. Multiple female reproductive failures in cyclooxygenase-2 deficient mice. Cell 1997; 91: 197-208.
13. Salhab AS, Gharaibeh MN, Shomaf MS, Amro BI. Meloxicam inhibits rabbit ovulation. Contraception 2001; 63: 329-333.
14. Salhab AS, Amro BI, Shomaf MS. Further investigation on meloxicam contraceptivity in female rabbits: luteinizing unruptured follicles, a microscopic evidence. Contraception 2003; 67: 485-489.
15. Lim H, Dey SK. Prostaglandin E2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation. Endocrinology 1997; 138: 4599-4606.
16. Das SK, Wang J, Dey SK, Mead RA. Spatiotemporal expression of cyclooxygenase-1 and Cyclooxygenase-2 during delayed implantation and the peri-implantation period in the western spotted shunk. Biol Reprod 1999; 60: 893-899.
17. Matsuo, Nishimura, Uchiyama, Suzuki, Katsuki, Reproduction and teratology study with meloxicam in rats dosed orally during perinatal and postnatal period. Oyo Yakuri 1997; 53: 75-86.
18. Matsuo A, Nishimura M, Uchiyama H, Suzuki T, Katsuki S. Fertility study with meloxicam in rats dosed orally before mating and during early period of gestation. Oyo Yakuri 1997; 53: 51-59.
19. Benneet Robert P. Cyclooxygenase-2 (COX-2) selective inhibitors for managing labor and uterine contractions. 1997; Patent no. WO 97-GB529.
20. 2 pathway in pregnant rat uteri, 1996 Am J Physiol 270 (pt.1), E471-E476.
21. 2- Adrenoceptor blockade on myometrial oxytocin receptors in parturient rats. Biol Reprod 1999; 60: 322-329.
22. Husslein P, Fuchs AR Fuchs F. Oxytocin and the initiation of human parturition prostaglandin release during induction of labor oxytocin. Am J Obstit Gynecol.
23. 2 alpha during luteal regression and early pregnancy in sheep. Rep Fer Dev 1992; 4: 321-328.
24. Baguma-Nibasheka M. In vivo administration of nimesulide, a selective PGH5-2 inhibitor, increases in vitro myometrial sensitivity to prostaglandins while lowering sensitivity to oxytocin. J Soc Gynecol Invest 1998; 5: 296-299.
25. Arias F. Pharmcology of oxytocin and prostaglandin. Clin Obstet Gynecol. 2000; 43: 455-468.